Evaluating the Anti-proliferative and Apoptotic Effects of <i>Sesamin</i> on SKOV3 Ovarian Cancer Cells: An Integrated <i>In Vitro</i> and <i>In Silico</i> Approach
Background: Ovarian cancer is among the most lethal gynaecological tumours because it is resistant to apoptosis and chemotherapy. Aim: The aim of the current study was to evaluate the cytotoxic and apoptotic effects of Sesamin on SKOV3 ovarian cancer cells and identify its molecular mechanisms. Methods: SKOV3 cells were exposed to Sesamin (75 ?M for 48 hours) and subjected to MTT assay, immunofluorescence microscopy, flow cytometry, western blotting, gene expression analysis, and molecular docking. Results: Sesamin treatment downregulated cell viability dose dependently and caused typical apoptotic morphological alterations such as chromatin condensation and nuclear fragmentation. Flow cytometry analysis indicated cell cycle arrest in the sub-G1 and G2/M phases, whereas Annexin V-FITC staining showed an enhanced apoptotic cell population. Western blotting and gene expression analyses proved upregulation of pro-apoptotic proteins (Bax, p53, and Caspase-9) and downregulation of anti-apoptotic proteins (Bcl-2 and Bcl-xL), showing activation of the intrinsic mitochondrial apoptotic pathway. Molecular docking study further attested to Sesamin's high binding affinity with crucial apoptotic regulators, further supporting Sesamin's apoptosis-inducing role. Conclusion: Sesamin has potent anti-tumour activity against SKOV3 ovarian cancer cells through the induction of apoptosis, suppression of cell proliferation, and interference with major survival pathways. The induction of pro-apoptotic proteins and suppression of anti-apoptotic regulators indicate that Sesamin triggers the intrinsic mitochondrial apoptotic pathway, increasing susceptibility of cancer cells to apoptosis. Furthermore, molecular docking analysis confirms its robust interaction with central apoptotic regulators, further establishing its mechanism of action. Our findings offer useful information regarding the molecular impact of Sesamin and highlight its potential as a viable therapeutic agent for the treatmen